BioLife Solutions Market Cap 2006-2020 | BLFS
BioLife Solutions market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. BioLife Solutions market cap as of July 13, 2020 is $0.62B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.620B | $0.027B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $164.573B | 28.54 |
| Medtronic (MDT) | Ireland | $121.803B | 19.78 |
| Stryker (SYK) | United States | $66.678B | 21.64 |
| Boston Scientific (BSX) | United States | $48.529B | 22.82 |
| Baxter (BAX) | United States | $43.229B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.790B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.034B | 0.00 |
| Terumo (TRUMY) | Japan | $28.019B | 35.82 |
| ResMed (RMD) | United States | $27.789B | 43.86 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.651B | 15.51 |
| Sunny Optical Technology (SNPTF) | China | $19.798B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.859B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.161B | 64.46 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $13.702B | 0.00 |
| Insulet (PODD) | United States | $13.110B | 1298.88 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $10.359B | 81.40 |
| GN STORE NORD (GNNDY) | Denmark | $7.527B | 38.37 |
| Perrigo (PRGO) | Ireland | $7.520B | 13.46 |
| Hill-Rom Holdings (HRC) | United States | $7.384B | 20.82 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $6.112B | 0.00 |
| Haemonetics (HAE) | United States | $4.436B | 26.64 |
| Neogen (NEOG) | United States | $4.094B | 69.35 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.971B | 0.00 |
| ICU Medical (ICUI) | United States | $3.820B | 27.86 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.796B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.644B | 0.00 |
| Abcam (ABCZY) | $3.447B | 0.00 | |
| Envista Holdings (NVST) | United States | $3.215B | 0.00 |
| NuVasive (NUVA) | United States | $2.805B | 22.52 |
| TG Therapeutics (TGTX) | United States | $2.618B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.314B | 40.03 |
| AtriCure (ATRC) | United States | $1.753B | 0.00 |
| MacroGenics (MGNX) | United States | $1.500B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.361B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.319B | 0.00 |
| Aphria (APHA) | Canada | $1.238B | 0.00 |
| Cerus (CERS) | United States | $1.120B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.112B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.032B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.025B | 38.60 |
| Phibro Animal Health (PAHC) | United States | $1.015B | 20.24 |
| PetIQ (PETQ) | United States | $0.992B | 28.64 |
| Vapotherm (VAPO) | United States | $0.983B | 0.00 |
| Zynex (ZYXI) | United States | $0.949B | 95.27 |
| OraSure Technologies (OSUR) | United States | $0.833B | 167.81 |
| InMode (INMD) | Israel | $0.826B | 17.45 |
| Quanterix (QTRX) | United States | $0.772B | 0.00 |
| Omeros (OMER) | United States | $0.742B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.663B | 47.50 |
| VAREX IMAGING (VREX) | United States | $0.586B | 14.54 |
| Lantheus Holdings (LNTH) | United States | $0.573B | 11.54 |
| Surmodics (SRDX) | United States | $0.570B | 68.62 |
| LeMaitre Vascular (LMAT) | United States | $0.519B | 29.58 |
| Owens & Minor (OMI) | United States | $0.459B | 12.13 |
| Viemed Healthcare (VMD) | United States | $0.408B | 36.17 |
| Cytosorbents (CTSO) | United States | $0.367B | 0.00 |
| HEXO (HEXO) | $0.334B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.330B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.302B | 21.93 |
| Organigram Holdings (OGI) | Canada | $0.269B | 0.00 |
| Female Health (VERU) | United States | $0.208B | 0.00 |
| Chimerix (CMRX) | United States | $0.190B | 0.00 |
| Surface Oncology (SURF) | United States | $0.163B | 0.00 |
| Bovie Medical (APYX) | United States | $0.163B | 0.00 |
| Fonar (FONR) | United States | $0.136B | 12.09 |
| Exagen (XGN) | United States | $0.134B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.125B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.122B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.117B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.115B | 0.00 |
| Evolus (EOLS) | United States | $0.108B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.078B | 0.00 |
| Nephros (NEPH) | United States | $0.066B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 15.32 |
| Trinity Biotech (TRIB) | Ireland | $0.064B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.062B | 0.00 |
| Brainsway (BWAY) | Israel | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.033B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.016B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
